Form 8-K

8-K — LifeMD, Inc.

Accession: 0001493152-26-042691

Filed: 2026-09-15

Period: 2026-09-15

CIK: 0000948320

SIC: 8011 (SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-99.1 (ex99-1.htm)

GRAPHIC (ex99-1_001.jpg)

GRAPHIC (ex99-1_002.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0000948320

2026-09-15

0000948320

LFMD:CommonStockParValue0.01PerShareMember

2026-09-15

0000948320

LFMD:Sec8.875SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember

2026-09-15

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

Washington,

D.C. 20549

FORM

8-K

CURRENT

REPORT

Pursuant

to Section 13 or 15(d) of the Securities and Exchange Act of 1934

Date

of Report (Date of earliest event reported): September 15, 2026

LIFEMD,

INC.

(Exact

name of Registrant as specified in its charter)

Delaware

001-39785

76-0238453

(State

or other jurisdiction

incorporation)

(Commission

File

Number)

(IRS

Employer

Identification

No.)

236

Fifth Avenue, Suite 400

New

York, NY 10001

(Address

of principal executive offices, including zip code)

(866)

351-5907

(Registrant’s

telephone number, including area code)

Check

the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any

of the following provisions:

☐

Written

communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock, par value $0.01 per share

LFMD

The

Nasdaq Global Market

8.875%

Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share

LFMDP

The

Nasdaq Global Market

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405)

or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging

growth company ☐

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

7.01 Regulation FD Disclosure.

September 15, 2026, LifeMD, Inc. (the “Company” or “LifeMD”) announced an exclusive strategic collaboration with

AT&T Services, Inc. (“AT&T”), whereby eligible AT&T wireless and fiber customers receive a complimentary LifeMD

membership.

The

parties entered into a Subscriber Health & Wellness Collaboration Agreement, providing for a multi-phase launch that will initially

cover a limited number of states and then expand into a nationwide offering. The Company initially will pay AT&T a fixed fee per

lead, with subsequent compensation to be negotiated. The parties will establish a joint steering committee to provide strategic oversight

and governance of the project and the parties’ respective obligations, including marketing, budget, creative, pricing, performance,

and dispute resolution.

Subject

to earlier termination under certain circumstances, the Agreement has an initial term of one year with automatic renewal for successive

one-year periods unless either party provides 90 days’ written notice of non-renewal. The agreements contain customary representations,

warranties and covenants by each of the parties, and indemnification provisions under which the parties have agreed, subject to certain

limitations, to indemnify each other against certain liabilities.

The

Company issued a press release announcing the exclusive partnership. A copy of the Company’s press release is attached hereto as

Exhibit 99.1 and is incorporated by reference herein.

The

Company makes no admission as to the materiality of any information in this Current Report on Form 8-K, including the press release,

that is required to be disclosed solely by reason of Regulation FD. The Company undertakes no duty or obligation to publicly update or

revise the information contained in this Current Report on Form 8-K, although it may do so from time to time as its management believes

is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or

through other public disclosure.

The

information provided under this Item 7.01 of this Current Report on Form 8-K, including the press release, is “furnished”

and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed

incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall

be expressly set forth by specific reference in such filing.

Cautionary

Statements Regarding Forward-Looking Information

This

Current Report on Form 8-K, including the press release, contains forward-looking statements within the meaning of the Private Securities

Litigation Reform Act of 1995, including, without limitation, statements regarding the expected launch timing, scope, pricing, and benefits

of the AT&T strategic collaboration; the duration of the program; the number of states in which the program will be available and

any potential expansion; the parties’ planned promotional and consumer education initiatives; expected patient demand and access;

and the anticipated benefits of the collaboration to patients and to each company. Words such as “expect,” “believe,”

“will,” “designed to,” “anticipate,” and similar expressions identify forward-looking statements.

These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual

results to differ materially, including risks related to the commercial launch and adoption of the program, changes in federal or state

laws governing telehealth prescribing of controlled substances, regulatory and compliance requirements applicable to telehealth, pharmacy,

and pharmaceutical promotion, and the other risks described in each company’s filings with the Securities and Exchange Commission,

including LifeMD’s most recent Annual Reports on Form 10-K and subsequent Quarterly Reports on Form 10-Q. The Company does not

undertake any obligation to update forward-looking statements except as required by law.

Item

9.01 Financial Statements and Exhibits.

(d)

Exhibits

Exhibit

No.

Description

99.1

Press Release dated September 15, 2026

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant

to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

LIFEMD,

INC.

Dated:

September

15, 2026

By:

/s/

Eric Yecies

Chief

Legal Officer and General Counsel

EX-99.1

Filename: ex99-1.htm · Sequence: 2

Exhibit

99.1

DALLAS,

September 15, 2026

AT&T

Becomes the First and Only Carrier to Offer Free Access to Virtual Healthcare Powered by LifeMD

Through

an exclusive collaboration with LifeMD, eligible AT&T wireless and fiber customers receive a complimentary LifeMD membership, a $228

annual value, with on-demand access to a nationwide virtual care and pharmacy platform.

Key

Takeaways:

● More

than 100 million eligible AT&T wireless and fiber customers will receive complimentary

access to LifeMD’s virtual care and pharmacy platform.

● The

$19-per-month LifeMD membership fee will be fully waived, a value of $228 per year.

● Members

can connect with providers for everyday health needs and prescriptions, with many medications

shipped directly from LifeMD’s pharmacy.

●

The benefit is available

through AT&T’s &More program, which allows members to unlock savings and special offers.

What’s

the News: AT&T is delivering more value to eligible wireless and fiber customers through an exclusive collaboration with LifeMD,

a leading virtual care and pharmacy services provider. Eligible customers receive a complimentary LifeMD membership, connecting them

to a nationwide virtual care and pharmacy platform that offers convenient access to healthcare from virtually anywhere.

Why

it Matters: More people are turning to virtual care to get the healthcare they need. A recent study revealed 82% of patients

said telemedicine helps them stay on track with their health, while 78% said it makes healthcare easier to access. Through LifeMD, AT&T

is helping remove barriers to care and medication access, giving customers a simpler way to manage their health.

Quotable:

“AT&T connects customers to the things that matter most, and healthcare is one of them. As virtual care becomes an increasingly

important option, this offer gives eligible customers a simpler, more accessible way to manage their well-being,” said Jenifer

Robertson, executive vice president & GM, AT&T Consumer. “Together with LifeMD, we’re using connectivity to expand

access to care and help more people get support when and where they need it.”

“AT&T

connects tens of millions of households across the country, and together we’re making something new available to them: a complete

virtual care and pharmacy experience,” said Justin Schreiber, Chairman and CEO of LifeMD. “This is a landmark moment

for LifeMD and, more importantly, for the millions of Americans who have been priced out of convenient, high-quality healthcare. Members

can reach a state-licensed provider from their phone at their convenience and get care for a wide range of everyday health needs. We’ve built the healthcare platform today’s consumer wants, and this collaboration puts it in front of one

of the largest customer bases in America.”

Details: Eligible customers must enroll to receive a complimentary LifeMD membership, helping put convenient care within reach without

a monthly fee. Once enrolled, customers can choose the care that meets their needs and pay only for the visits, prescriptions, or services

they use.

million AT&T customers in 11 states will be the first to receive this new benefit, with additional markets joining in January 2027

as it expands nationwide. Customers can learn more and enroll through the AT&T website or the AT&T mobile app.

Frequently

Asked Questions:

● Q:

Who is eligible* for the LifeMD benefit?

○ All

current AT&T wireless and fiber customers are eligible for complimentary access to LifeMD’s

virtual care and pharmacy platform. The benefit will initially be available in select states

(AZ, FL, NC, IL, MD, NM, IA, TX, NY, CA, and MI), with expansion to additional states planned

for January 2027.

*Not all offerings are available in all states. Customers must be 18 or older. Some offerings may have additional eligibility restrictions.

● Q:

What does “complimentary access” include?

○ AT&T

customers receive LifeMD membership at no cost, with the $19 monthly membership fee fully

waived. Members pay only for the care they need, with visits starting at $29 for message-based

care, $49 for urgent and primary care video visits with state-licensed providers, and $79

for specialty care. For visits and prescriptions, customers can choose to use insurance,

Medicare, or discounted cash-pay rates. AT&T customers will have access to LifeMD’s

nationwide virtual care and pharmacy platform, including:

■ Virtual

primary care and 24/7 urgent care, with same-day prescriptions for common conditions like

infections, allergies, and asthma

■ Ongoing

medications for chronic conditions such as high blood pressure and high cholesterol

■ Weight

management, including GLP-1 medications

■ Women’s

health, including perimenopause and menopause care and hormone replacement therapy

■ Men’s

health, including testosterone and sexual health treatment

■ Prescription

dermatology, hormone health, sleep, and laboratory services

■ Same-day

prescriptions and refills, when clinically appropriate, with many medications shipped directly

from LifeMD’s pharmacy and others sent to the member’s local pharmacy

● Q:

How do customers sign up for the benefit?

○ Customers

can learn more about the benefit and enroll through the AT&T website, mobile app,

and other digital channels. Once enrolled, they can use the LifeMD platform to connect with

state-licensed providers, fill and manage prescriptions through LifeMD’s pharmacy,

and access a range of virtual care services.

Limited time offer. Only monthly fee waived; costs of care, visits, and prescriptions not included. Not available in all states. Customers

must be 18 or older. Additional restrictions and requirements may apply. See here for more details, terms, and conditions.

About

AT&T

help more than 100 million U.S. families, friends and neighbors, plus nearly 2.5 million businesses, connect to greater possibility.

From the first phone call 150 years ago to our 5G wireless and multi-gig internet offerings today, we @ATT innovate to improve lives.

For more information about AT&T Inc. (NYSE:T), please visit us at about.att.com. Investors can learn more at investors.att.com.

About

LifeMD

LifeMD®

(Nasdaq: LFMD) is a leading virtual care company making high-quality healthcare more accessible, convenient, and affordable. Through

its vertically integrated platform, LifeMD connects patients with a 50-state affiliated medical group, laboratory services, a state-of-the-art

nationwide pharmacy with home delivery, and a U.S.-based patient care center. Together, these capabilities support care across more than

200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. For more information,

please visit LifeMD.com.

GRAPHIC

Filename: ex99-1_001.jpg · Sequence: 3

Binary file (6858 bytes)

Download ex99-1_001.jpg

GRAPHIC

Filename: ex99-1_002.jpg · Sequence: 4

Binary file (328329 bytes)

Download ex99-1_002.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 10

v3.26.3

Cover

Sep. 15, 2026

Document Type

8-K

Amendment Flag

false

Document Period End Date

Sep. 15, 2026

Entity File Number

001-39785

Entity Registrant Name

LIFEMD,

INC.

Entity Central Index Key

0000948320

Entity Tax Identification Number

76-0238453

Entity Incorporation, State or Country Code

Entity Address, Address Line One

236

Fifth Avenue

Entity Address, Address Line Two

Suite 400

Entity Address, City or Town

New

York

Entity Address, State or Province

Entity Address, Postal Zip Code

10001

City Area Code

(866)

Local Phone Number

351-5907

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Entity Emerging Growth Company

false

Common Stock, par value $0.01 per share

Title of 12(b) Security

Common

Stock, par value $0.01 per share

Trading Symbol

LFMD

Security Exchange Name

NASDAQ

8.875% Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share

Title of 12(b) Security

8.875%

Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share

Trading Symbol

LFMDP

Security Exchange Name

NASDAQ

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

us-gaap_StatementClassOfStockAxis=LFMD_CommonStockParValue0.01PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type:

- Details

Name:

us-gaap_StatementClassOfStockAxis=LFMD_Sec8.875SeriesCumulativePerpetualPreferredStockParValue0.0001PerShareMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: